SIMULECT subst seche 20 mg 1 pce
7680695420012
CH-69542
L04AC02
07.15.0.
1 / 3
google
Details
- Product number
- 6954201
- CPT
- -
- Packaging group
- 1
- Unit
- Durchstechflasche(n)
- Composition
- basiliximabum 20 mg, mannitolum, glycinum, saccharum, dinatrii phosphas, kalii dihydrogenophosphas, natrii chloridum, pro vitro corresp. natrium 0.955 mg.
Articles (1)
Simulect 20 mg, Pulver zur Herstellung einer Injektions-/Infusionslösung
Pulver
1
Official Swissmedic V2 data
Additional information from the official database
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
20.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
0.955 MG | Substance | HBESI |
Authorization holder
Novartis Pharma Schweiz AG
6343 Risch
Authorization information
- Swissmedic authorization number
- 69542
- Drug name
- Simulect, Pulver zur Herstellung einer Injektions-/Infusionslösung
- Galenic form
- PULVII
- ATC Code
- L04AC02
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 26/10/2023
- Authorization expiration date
- 25/10/2028
- IT number
- 07.15.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- SIMULECT subst seche 20 mg 1 pce
- Description (DE)
- SIMULECT Trockensub 20 mg 1 Stk
- Market launch
- 15/03/2024
- Narcotic (BTM)
- No